Pharmacy Articles

Pharmacy

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Haile CN et al. - Disulfiram and methylphenidate pharmacotherapies for cocaine addiction are optimized by considering polymorphisms affecting DbetaH and DAT1 respectively. Altered subjective effects for amphetamine in DAT1 VNTR variants suggest a 'protected' phenotype.

Related Articles

Drug use and addiction: evolutionary perspective
Australian and New Zealand Journal of Psychiatry, 11/04/09    Relevance Score: 70%

NIDA Launches New Substance Abuse Resources to Help Fill Gaps in Medical Education
AMN Healthcare, 11/17/09    Relevance Score: 67%

Drug addiction during pregnancy: Correlations between the placental health and the newborns outcome - Elaboration of a predictive score
Gynecological Endocrinology, 11/16/09    Relevance Score: 67%

The Neurobiology of Addictive Disorders
Clinical Neuropharmacology, 10/13/09    Relevance Score: 67%

Assessment of hepatitis C infection in injecting drug users attending an addiction treatment clinic
Irish Journal of Medical Science, 10/21/09    Relevance Score: 66%

Today in Drug Interactions...keeping you current

Acetazolamide and midazolam act synergistically to inhibit neuropathic pain
Pain, 12/16/09

Cyclosporine Versus Tacrolimus in Immunosuppressive Maintenance Regimens in Renal Transplants in Brazil: Survival Analysis from 2000 to 2004
Annals of Pharmacotherapy, 12/16/09

'Party pill' drugs - BZP and TFMPP
New Zealand Medical Journal, 12/14/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address